JCP174
CAS: 126062-19-9
Ref. 3D-BFA06219
| 1mg | 338.00 € | ||
| 5mg | 585.00 € | ||
| 10mg | 892.00 € | ||
| 25mg | 1,573.00 € | ||
| 50mg | 2,517.00 € |
Product Information
JCP174 is a small molecule that inhibits the life cycle of Toxoplasma gondii. It encompasses the development of toxoplasmosis, which is a disease caused by this organism. JCP174 has been shown to be an achievable drug candidate for the treatment of toxoplasmosis and other diseases. The nature of JCP174's action against Toxoplasma gondii is unknown, but it may involve the disruption of the parasite's fatty acid synthesis. There are many techniques for profiling JCP174, including fluorogenic substrates and cellular assays. These techniques are useful in determining how to improve its potency, selectivity, and pharmacokinetics.
Chemical properties
Technical inquiry about: 3D-BFA06219 JCP174
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
